Magnetic Sphincter Augmentation and Postoperative Dysphagia: Characterization, Clinical Risk Factors, and Management - Takeaways - MDSpire

Magnetic Sphincter Augmentation and Postoperative Dysphagia: Characterization, Clinical Risk Factors, and Management

  • By

  • Shahin Ayazi

  • Ping Zheng

  • Ali H. Zaidi

  • Kristy Chovanec

  • Nobel Chowdhury

  • Madison Salvitti

  • Yoshihiro Komatsu

  • Ashten N. Omstead

  • Toshitaka Hoppo

  • Blair A. Jobe

  • August 6, 2019

  • 0 min

Share

  • 1

    Gastroesophageal reflux disease (GERD) affects approximately 25% of the adult population in the USA and is a leading cause of gastrointestinal medical visits.

  • 2

    Magnetic sphincter augmentation (MSA) was approved by the FDA in 2012 and is a safe, effective treatment for GERD, offering comparable outcomes to laparoscopic fundoplication.

  • 3

    Postoperative dysphagia is a common complaint after MSA, affecting 43-83% of patients, with most cases resolving within 8 weeks.

  • 4

    Persistent dysphagia after MSA may require endoscopic dilation or device removal, but factors predicting this complication are not well characterized.

  • 5

    The study conducted a retrospective review of patients undergoing MSA to assess dysphagia management and identify preoperative predictors of persistent symptoms.

Original Source(s)

Related Content